Numis Securities reissued their hold rating on shares of ConvaTec Group (LON:CTEC) in a research report released on Thursday. Numis Securities currently has a GBX 180 ($2.49) price target on the stock.
CTEC has been the topic of a number of other reports. Deutsche Bank reiterated a sell rating and issued a GBX 180 ($2.49) price objective on shares of ConvaTec Group in a report on Friday, December 1st. Peel Hunt reiterated a hold rating and issued a GBX 250 ($3.45) price objective on shares of ConvaTec Group in a report on Tuesday, October 31st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus price target of GBX 244.67 ($3.38).
Shares of ConvaTec Group (LON CTEC) opened at GBX 215.30 ($2.97) on Thursday. ConvaTec Group has a fifty-two week low of GBX 181.40 ($2.51) and a fifty-two week high of GBX 349.10 ($4.82). The stock has a market cap of $4,200.00 and a P/E ratio of 3,588.33.
In other news, insider Ros Rivaz bought 4,821 shares of the firm’s stock in a transaction that occurred on Wednesday, December 6th. The stock was acquired at an average cost of GBX 206 ($2.85) per share, with a total value of £9,931.26 ($13,721.00).
ILLEGAL ACTIVITY WARNING: “ConvaTec Group (CTEC) Stock Rating Reaffirmed by Numis Securities” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/18/convatec-group-ctec-stock-rating-reaffirmed-by-numis-securities.html.
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.